| Dr Matthew Nathaniel Dawson, MD | |
|
2331 Franklin Rd Sw, Roanoke, VA 24014-1111 | |
| (540) 224-5170 | |
| (540) 857-5306 |
| Full Name | Dr Matthew Nathaniel Dawson |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 11 Years |
| Location | 2331 Franklin Rd Sw, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003159021 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ingalls Memorial Hospital | Harvey, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Holzer Clinic Llc | 5890606008 | 268 |
| Medical Services Ric | 4880598978 | 85 |
| North Memorial Health Care | 0042123028 | 483 |
News Archive
Terumo Cardiovascular Group introduces the newest addition to the CAPIOX Oxygenator portfolio – the CAPIOX FX Advance Oxygenator. The CAPIOX FX Advance replaces the current CAPIOX FX15 and FX25 line of oxygenators manufactured in Elkton, Maryland.
Premiums for employer-sponsored family health insurance increased by 50 percent from 2003 to 2010, and the annual amount that employees pay toward their insurance increased by 63 percent as businesses required employees to contribute a greater share, according to a new Commonwealth Fund report that examines state trends in health insurance costs.
Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.
Palatin Technologies, Inc. today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood pressure effects and support the continued development of bremelanotide.
The team led by Manel Esteller, director of the Cancer Epigenetics and Biology Program in the Bellvitge Biomedical Research Institute (IDIBELL), Professor of Genetics at the University of Barcelona and ICREA researcher, has identified epigenetic changes that occur in adult stem cells to generate different body tissues. The finding is published this week in The American Journal of Pathology.
› Verified 7 days ago
| Entity Name | Holzer Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508817248 PECOS PAC ID: 5890606008 Enrollment ID: O20031215000746 |
News Archive
Terumo Cardiovascular Group introduces the newest addition to the CAPIOX Oxygenator portfolio – the CAPIOX FX Advance Oxygenator. The CAPIOX FX Advance replaces the current CAPIOX FX15 and FX25 line of oxygenators manufactured in Elkton, Maryland.
Premiums for employer-sponsored family health insurance increased by 50 percent from 2003 to 2010, and the annual amount that employees pay toward their insurance increased by 63 percent as businesses required employees to contribute a greater share, according to a new Commonwealth Fund report that examines state trends in health insurance costs.
Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.
Palatin Technologies, Inc. today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood pressure effects and support the continued development of bremelanotide.
The team led by Manel Esteller, director of the Cancer Epigenetics and Biology Program in the Bellvitge Biomedical Research Institute (IDIBELL), Professor of Genetics at the University of Barcelona and ICREA researcher, has identified epigenetic changes that occur in adult stem cells to generate different body tissues. The finding is published this week in The American Journal of Pathology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Nathaniel Dawson, MD 213 S Jefferson St Ste 625, Roanoke, VA 24011-1713 Ph: (540) 224-5516 | Dr Matthew Nathaniel Dawson, MD 2331 Franklin Rd Sw, Roanoke, VA 24014-1111 Ph: (540) 224-5170 |
News Archive
Terumo Cardiovascular Group introduces the newest addition to the CAPIOX Oxygenator portfolio – the CAPIOX FX Advance Oxygenator. The CAPIOX FX Advance replaces the current CAPIOX FX15 and FX25 line of oxygenators manufactured in Elkton, Maryland.
Premiums for employer-sponsored family health insurance increased by 50 percent from 2003 to 2010, and the annual amount that employees pay toward their insurance increased by 63 percent as businesses required employees to contribute a greater share, according to a new Commonwealth Fund report that examines state trends in health insurance costs.
Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.
Palatin Technologies, Inc. today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood pressure effects and support the continued development of bremelanotide.
The team led by Manel Esteller, director of the Cancer Epigenetics and Biology Program in the Bellvitge Biomedical Research Institute (IDIBELL), Professor of Genetics at the University of Barcelona and ICREA researcher, has identified epigenetic changes that occur in adult stem cells to generate different body tissues. The finding is published this week in The American Journal of Pathology.
› Verified 7 days ago
Lydia L Mcneary, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2331 Franklin Rd Sw, Roanoke, VA 24014 Phone: 540-510-6200 | |
Dr. Donald James Arthur, M.D., MSC, MBA Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2331 Franklin Rd Sw, Roanoke, VA 24014 Phone: 540-224-5170 Fax: 540-857-5306 | |
Dr. Andrea Rose Conti, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2331 Franklin Rd Sw, Roanoke, VA 24014 Phone: 540-224-5170 | |
Mr. Ricky Randall Lapradd Jr., A.T.C. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2102 Grandin Rd Sw, Roanoke, VA 24015 Phone: 540-853-2158 | |
Dr. Daniel P Moore, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2331 Franklin Rd Sw, Roanoke, VA 24014 Phone: 540-224-5170 Fax: 540-857-5306 | |
Mrs. Verna M Lewis, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2328 Peters Creek Rd Nw, Roanoke, VA 24017 Phone: 540-400-7765 Fax: 540-400-7555 |